Cancer Registry Software Market is estimated to reach at 2.20 million by 2026

Posted by Harsh on June 29th, 2021

Global Cancer Registry Software Market is accounted for .20 million in 2017 and is expected to reach 2.20 million by 2026 growing at a CAGR of 11.2% from 2017 to 2026. Some of the factors such as increase in prevalence of cancer and favorable government initiatives are impelling the market growth. However privacy and data security-related concerns are restricting the market growth. Increase in number of accountable care organizations is creating ample opportunities for the market growth.

Cancer Registry Software is a particular type of disease registry that is mainly used in order to establish and maintain a cancer incidence reporting system. The cancer registry system acts as an informational resource for the investigation of cancer and its causes. This type of registry is important as cancer is among the leading causes of death and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial in order to help identify trends and ultimately improve care for patients that are fighting cancer.

Based on type, the standalone software segment accounted for a larger share primarily due to the significant use of standalone software by government organizations & TPAs for population health management (due to its adaptability and interoperability). Also, standalone software provides practical and easy-to-use tools to store and process registry data, while standalone software customized for patient registries offers higher flexibility and features such as multiple system usage and automatic upgradation. Based on the geography, North America dominated the market growth due to the high burden of cancer, government funding initiatives to encourage the development of cancer registries.

Sample Report with Latest Industry Trends @ https://www.trendsmarketresearch.com/report/sample/13586 

Some of the key players in Cancer Registry Software market include, Onco, Inc., Rocky Mountain Cancer Data Systems, Mckesson Corporation, Elekta AB (PUB), C/Net Solutions and Electronic Registry Systems, Inc.

Types Covered:
• Integrated Software
• Standalone Software

Deployment Models Covered:
• Cloud-Based Models
• On-Premise Models

Database Types Covered:
• Commercial Databases
• Public Databases

Functionalities Covered:
• Patient Care Management
• Product Outcome Evaluation
• Cancer Reporting to Meet State and Federal Regulations
• Medical Research & Clinical Studies

End Users Covered:
• Hospitals & Medical Practices
• Government Organizations & Third-Party Administrators
• Pharmaceutical, Biotechnology, and Medical Device Companies
• Private Payers
• Research Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe

• Asia Pacific
  • Japan       
  • China       
  • India       
  • Australia 
  • New Zealand     
  • South Korea      
  • Rest of Asia Pacific   
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Get Impressive Discount@ https://www.trendsmarketresearch.com/report/discount/13586